Covance Will Soon Be Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.


Coordinating Global Capabilities to Support a Gene Therapy Targeting a Rare Neurodegenerative Disorder

An emerging biotech company and Covance teamed up in early phase efforts to advance a gene therapy that targeted a rare neurodegenerative disease. Learn how multiple teams across Covance collaborated to support the biotech's successful IND with GLP toxicology and biodistribution study and CMC services for the sponsor's unique program.